Artiman Ventures: Big Data in drug Discovery

Artiman ventures and the team reviews the big data in drug discovery. Ajit Singh, previous

CEO of Biolmagene, accomplice of Artiman Ventures tries to comprehend this activity with

other board parts from regarded social insurance organizations.

From Google tracking flu outbreaks via search behavior to companies seeking to reposition

drugs based on in silico analysis, samples flourish of medicinal services being influenced by

Big Data.

At the same time dissimilar to most markets effectively handled by Big Data, life sciences

markets are heavily regulated and traditional methods are deeply entrenched. Still, Big Data

is making advances.

We talk about the effect of information dissection on pill disclosure, VC venture and

medicinal services